Latest vaccine candidate News | Page 2

Vaxxas awarded Wellcome grant for needle-free typhoid vaccine patch study
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Vaccine breakthrough offers hope against EBV-associated cancers and MS
Moderna submits RSV vaccine to global regulatory agencies
Organoids shown to speed glycoengineered vaccine development
SAGE updates COVID-19 vaccination guidance
Volunteers needed for ‘Clamp2’ vaccine testing
Victoria to skill-up Asia Pacific’s future mRNA medicines manufacturing workforce
Industry collaborations progress research in advanced imaging and vaccination
Preventing costly cattle disease to boost fertility rates
Griffith unlocking secrets to Strep virulence
WHO: Invest in New TB Vaccines for Health, Economic Gains
Experimental vaccines offer long-term protection against severe COVID
Honourable Anna Bligh AC joins forces with Griffith University to fight malaria
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
Researchers find Strep A’s Achilles heel with potential vaccine to prevent rheumatic heart disease
CSL Enters Licensing Agreement
Burnet welcomes grant for mRNA vaccine development
QIMR Berghofer grants and license agreement for potential vaccine
WHO and partners launch new online resource to advance STI vaccine development
CSIRO opens ‘missing link’ lab to developing Australian vaccine pipeline
Victoria’s first mRNA innovation hub backed by state government
Tuberculosis vaccine passes safety test
COVID vaccine patch fights variants better than needles
Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR
TGA grants provisional determinations to Pfizer for Covid vaccines to target Omicron variant
QIMR Berghofer breakthrough in Cytomegalovirus vaccine research
Interim statement on composition of current Covid vaccines
Victorian mRNA Research Acceleration Grants Announced
New type of pneumococcal vaccine developed by KI scientists
WHO and MPP announce agreement with NIH for Covid health technologies
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
Partnership to develop ‘variant-proof’ Covid vaccine
Over 1 million African children protected by first malaria vaccine
Intranasal vaccine may deter antibiotic-resistant bacterium
Monash University world’s best for Pharmacy and Pharmacology in QS rankings
Monash No.1 World Rank Confirms Victorian Excellence
Recruitment commences for Phase 1 clinical trial of two Melbourne-made Covid vaccines
Doherty Institute secures landmark agreement with Moderna to expedite vaccine research for infectious diseases
Spend billions, save trillions: it’s in rich nations’ self-interest to vaccinate world
Technovalia announces interim safety results from vaccine phase 1 trial
Microscope zooms in on JCU research
Backing World-Leading Research Into Covid Treatments
Victoria To Become Home Of mRNA Vaccine Manufacturing
Record Support For Breakthrough mRNA Research
Bold new agenda to keep Victoria at forefront of innovation
Successful manufacture of Monash’s Covid mRNA vaccine candidate
Victoria produces Australia’s first mRNA Covid vaccine candidate